The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ingalls Kerry D. since 2021.
This trader's CIK number is 1816804.
At the time of last reporting, Ingalls Kerry D. was the Chief Operating Officer of Poseida Therapeutics, Inc.. (stock ticker symbol PSTX).
Also see all insider trading activities at Poseida Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PSTX | 3,000 | $11,940 | 0 | $0 | 0 | $0 |
| 2021 | PSTX | 2,000 | $14,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-16 | PSTX | Buy | 3,000 | 3.98 | 11,940 |
| 2021-11-17 | PSTX | Buy | 2,000 | 7.00 | 14,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ingalls Kerry D. (Chief Operating Officer of Poseida Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.